Tapewire

Nasdaq · USD

NPCE

NeuroPace Inc

Export transactions ↓
Tapewire entity
5459
SEC CIK
0001528287
Parsed reports
185

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 24, 2026 Filed Sep 25, 2026 20:31 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 335 $13.97 $4,679.95
Disclosure

SEC source: 0001855616-26-000024 · wk-form4_1790368295.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,357

F1 · shares: Represents the number of shares withheld by the Issuer on September 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on September 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
September 20, 2026 Filed Sep 21, 2026 20:56 UTC
Williams Patrick F.Chief Financial Officer
Tax withholdingCommon Stock 1,162 $14.28 $16,593.36
Disclosure

SEC source: 0001562229-26-000005 · wk-form4_1790024175.xml · nonDerivative · entry 1

Williams Patrick F. · CIK 0001562229 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,508

F1 · shares: Represents the number of shares withheld by the Issuer on September 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on September 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 21:42 UTC
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 1,310 $14.75 $19,322.50
Disclosure

SEC source: 0001533175-26-000016 · wk-form4_1788558148.xml · nonDerivative · entry 1

Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,000

F1 · shares: 1. Represents the number of shares withheld by the Issuer on September 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: 1. Represents the number of shares withheld by the Issuer on September 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
August 27, 2026 Filed Aug 28, 2026 17:03 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 358 $14.13 $5,058.54
Disclosure

SEC source: 0001855616-26-000022 · wk-form4_1787950985.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,692

F1 · shares: Represents the number of shares withheld by the Issuer on August 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on August 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
August 27, 2026 Filed Aug 28, 2026 17:04 UTC
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 1,126 $14.13 $15,910.38
Disclosure

SEC source: 0001533175-26-000014 · wk-form4_1787951045.xml · nonDerivative · entry 1

Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,310

F1 · shares: Represents the number of shares withheld by the Issuer on August 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on August 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
June 24, 2026 Filed Jun 25, 2026 20:12 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 335 $16.22 $5,433.70
Disclosure

SEC source: 0001855616-26-000019 · wk-form4_1782418320.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,050

F1 · shares: Represents the number of shares withheld by the Issuer on June 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on June 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
June 19, 2026 Filed Jun 22, 2026 20:34 UTC
Geiger UriDirector
GrantCommon Stock 789 $15.63 $12,332.07
Disclosure

SEC source: 0001467361-26-000005 · wk-form4_1782160441.xml · nonDerivative · entry 1

Geiger Uri · CIK 0001467361 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,537

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
June 19, 2026 Filed Jun 22, 2026 20:33 UTC GrantCommon Stock 1,467 $15.63 $22,929.21
Disclosure

SEC source: 0001297260-26-000007 · wk-form4_1782160401.xml · nonDerivative · entry 1

Fischer Frank M · CIK 0001297260 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 599,534

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
June 19, 2026 Filed Jun 22, 2026 20:32 UTC
Kumar RakhiDirector
GrantCommon Stock 989 $15.63 $15,458.07
Disclosure

SEC source: 0001856296-26-000007 · wk-form4_1782160357.xml · nonDerivative · entry 1

Kumar Rakhi · CIK 0001856296 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,039

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:09 UTC
Ryan ReneeDirector
GrantStock Option (Right to Buy) · Derivative 5,368 $0.00 Strike: $15.74 $0.00
Disclosure

SEC source: 0001855576-26-000002 · wk-form4_1780693777.xml · derivative · entry 2

Ryan Renee · CIK 0001855576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,368

Underlying: Common Stock · 5,368 shares

Expires 2036-06-04

F2 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:09 UTC
Ryan ReneeDirector
GrantCommon Stock 2,890 $0.00 $0.00
Disclosure

SEC source: 0001855576-26-000002 · wk-form4_1780693777.xml · nonDerivative · entry 1

Ryan Renee · CIK 0001855576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,890

F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:10 UTC
Geiger UriDirector
GrantStock Option (Right to Buy) · Derivative 5,368 $0.00 Strike: $15.74 $0.00
Disclosure

SEC source: 0001467361-26-000003 · wk-form4_1780693831.xml · derivative · entry 3

Geiger Uri · CIK 0001467361 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,368

Underlying: Common Stock · 5,368 shares

Expires 2036-06-04

F3 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:10 UTC
Geiger UriDirector
GrantCommon Stock 2,890 $0.00 $0.00
Disclosure

SEC source: 0001467361-26-000003 · wk-form4_1780693831.xml · nonDerivative · entry 1

Geiger Uri · CIK 0001467361 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,748

F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:10 UTC GrantStock Option (Right to Buy) · Derivative 5,368 $0.00 Strike: $15.74 $0.00
Disclosure

SEC source: 0001297260-26-000005 · wk-form4_1780693848.xml · derivative · entry 2

Fischer Frank M · CIK 0001297260 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,368

Underlying: Common Stock · 5,368 shares

Expires 2036-06-04

F2 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:10 UTC GrantCommon Stock 2,890 $0.00 $0.00
Disclosure

SEC source: 0001297260-26-000005 · wk-form4_1780693848.xml · nonDerivative · entry 1

Fischer Frank M · CIK 0001297260 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 598,067

F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:13 UTC GrantStock Option (Right to Buy) · Derivative 5,368 $0.00 Strike: $15.74 $0.00
Disclosure

SEC source: 0001628280-26-041324 · wk-form4_1780694002.xml · derivative · entry 2

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,368

Underlying: Common Stock · 5,368 shares

Expires 2036-06-04

F2 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:13 UTC GrantCommon Stock 2,890 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-041324 · wk-form4_1780694002.xml · nonDerivative · entry 1

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,890

F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:10 UTC
Kumar RakhiDirector
GrantStock Option (Right to Buy) · Derivative 5,368 $0.00 Strike: $15.74 $0.00
Disclosure

SEC source: 0001856296-26-000005 · wk-form4_1780693812.xml · derivative · entry 2

Kumar Rakhi · CIK 0001856296 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,368

Underlying: Common Stock · 5,368 shares

Expires 2036-06-04

F2 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:10 UTC
Kumar RakhiDirector
GrantCommon Stock 2,890 $0.00 $0.00
Disclosure

SEC source: 0001856296-26-000005 · wk-form4_1780693812.xml · nonDerivative · entry 1

Kumar Rakhi · CIK 0001856296 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,050

F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:09 UTC
Andrade LisaDirector
GrantStock Option (Right to Buy) · Derivative 5,368 $0.00 Strike: $15.74 $0.00
Disclosure

SEC source: 0001595202-26-000002 · wk-form4_1780693739.xml · derivative · entry 2

Andrade Lisa · CIK 0001595202 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,368

Underlying: Common Stock · 5,368 shares

Expires 2036-06-04

F2 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 05, 2026 Filed Jun 5, 2026 21:09 UTC
Andrade LisaDirector
GrantCommon Stock 2,890 $0.00 $0.00
Disclosure

SEC source: 0001595202-26-000002 · wk-form4_1780693739.xml · nonDerivative · entry 1

Andrade Lisa · CIK 0001595202 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,890

F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
June 03, 2026 Filed Jun 4, 2026 20:03 UTC
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 1,255 $15.88 $19,929.40
Disclosure

SEC source: 0001533175-26-000011 · wk-form4_1780603384.xml · nonDerivative · entry 1

Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,436

F1 · shares: Represents the number of shares withheld by the Issuer on June 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on June 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
May 27, 2026 Filed May 28, 2026 20:40 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 358 $17.06 $6,107.48
Disclosure

SEC source: 0001855616-26-000017 · wk-form4_1780000834.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,385

F1 · shares: Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
May 27, 2026 Filed May 28, 2026 20:42 UTC
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 1,126 $17.06 $19,209.56
Disclosure

SEC source: 0001533175-26-000009 · wk-form4_1780000959.xml · nonDerivative · entry 1

Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,691

F1 · shares: Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:27 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
GrantStock Option (Right to Buy) · Derivative 14,550 $0.00 Strike: $15.36 $0.00
Disclosure

SEC source: 0001855616-26-000015 · wk-form4_1779222436.xml · derivative · entry 2

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,550

Underlying: Common Stock · 14,550 shares

Expires 2036-05-14

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:27 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
GrantCommon Stock 5,460 $0.00 $0.00
Disclosure

SEC source: 0001855616-26-000015 · wk-form4_1779222436.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,743

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:51 UTC
Williams Patrick F.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 44,800 $0.00 Strike: $15.36 $0.00
Disclosure

SEC source: 0001562229-26-000002 · form4-05192026_080535.xml · derivative · entry 2

Williams Patrick F. · CIK 0001562229 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,800

Underlying: Common Stock · 44,800 shares

Expires 2036-05-14

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:51 UTC
Williams Patrick F.Chief Financial Officer
GrantCommon Stock 16,820 $0.00 $0.00
Disclosure

SEC source: 0001562229-26-000002 · form4-05192026_080535.xml · nonDerivative · entry 1

Williams Patrick F. · CIK 0001562229 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,670

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:26 UTC
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
GrantStock Option (Right to Buy) · Derivative 122,190 $0.00 Strike: $15.36 $0.00
Disclosure

SEC source: 0001533175-26-000007 · wk-form4_1779222368.xml · derivative · entry 2

Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,190

Underlying: Common Stock · 122,190 shares

Expires 2036-05-14

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:26 UTC
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
GrantCommon Stock 45,880 $0.00 $0.00
Disclosure

SEC source: 0001533175-26-000007 · wk-form4_1779222368.xml · nonDerivative · entry 1

Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,817

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
March 24, 2026 Filed Mar 25, 2026 20:20 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 1,341 $13.27 $17,795.07
Disclosure

SEC source: 0001855616-26-000011 · wk-form4_1774470047.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,283

F1 · shares: Represents the number of shares withheld by the Issuer on March 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on March 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
March 20, 2026 Filed Mar 23, 2026 20:41 UTC GrantCommon Stock 1,826 $13.00 $23,738.00
Disclosure

SEC source: 0001297260-26-000003 · wk-form4_1774298494.xml · nonDerivative · entry 1

Fischer Frank M · CIK 0001297260 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 595,177

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
March 20, 2026 Filed Mar 23, 2026 20:42 UTC
Kumar RakhiDirector
GrantCommon Stock 1,153 $13.00 $14,989.00
Disclosure

SEC source: 0001856296-26-000003 · wk-form4_1774298557.xml · nonDerivative · entry 1

Kumar Rakhi · CIK 0001856296 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,160

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 20:47 UTC
Geiger UriDirector
GrantCommon Stock 913 $13.00 $11,869.00
Disclosure

SEC source: 0001628280-26-020837 · wk-form4_1774385234.xml · nonDerivative · entry 1

Geiger Uri · CIK 0001467361 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,858

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 20:45 UTC
LACOB JOSEPHDirector
GrantCommon Stock 865 $13.00 $11,245.00
Disclosure

SEC source: 0001628280-26-020835 · wk-form4_1774385141.xml · nonDerivative · entry 1

LACOB JOSEPH · CIK 0001215490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,754

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
March 03, 2026 Filed Mar 4, 2026 21:43 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 1,340 $13.83 $18,532.20
Disclosure

SEC source: 0001855616-26-000007 · wk-form4_1772660606.xml · nonDerivative · entry 2

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,624

F3 · shares: Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
March 03, 2026 Filed Mar 4, 2026 21:41 UTC
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 5,023 $13.83 $69,468.09
Disclosure

SEC source: 0001533175-26-000004 · wk-form4_1772660493.xml · nonDerivative · entry 1

Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,937

F1 · shares: Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 17:51 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 358 $14.58 $5,219.64
Disclosure

SEC source: 0001855616-26-000005 · wk-form4_1772473884.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,964

F1 · shares: Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 21:46 UTC
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 1,126 $14.58 $16,417.08
Disclosure

SEC source: 0001533175-26-000002 · wk-form4_1772487987.xml · nonDerivative · entry 1

Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,960

F1 · shares: Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
February 20, 2026 Filed Feb 23, 2026 22:31 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 3,412 $14.34 $48,928.08
Disclosure

SEC source: 0001855616-26-000003 · wk-form4_1771885895.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,322

F1 · shares: Represents the number of shares withheld by the Issuer on February 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

F1 · price: Represents the number of shares withheld by the Issuer on February 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 21:15 UTC
Geiger UriDirector
GrantCommon Stock 715 $16.59 $11,861.85
Disclosure

SEC source: 0001467361-25-000005 · form4-12232025_041220.xml · nonDerivative · entry 1

Geiger Uri · CIK 0001467361 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,945

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 21:15 UTC GrantCommon Stock 1,431 $16.59 $23,740.29
Disclosure

SEC source: 0001297260-25-000006 · form4-12232025_041217.xml · nonDerivative · entry 1

Fischer Frank M · CIK 0001297260 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 593,351

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 21:15 UTC
LACOB JOSEPHDirector
GrantCommon Stock 678 $16.59 $11,248.02
Disclosure

SEC source: 0001215490-25-000007 · form4-12232025_041223.xml · nonDerivative · entry 1

LACOB JOSEPH · CIK 0001215490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,889

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 21:15 UTC
Kumar RakhiDirector
GrantCommon Stock 904 $16.59 $14,997.36
Disclosure

SEC source: 0001856296-25-000005 · form4-12232025_041221.xml · nonDerivative · entry 1

Kumar Rakhi · CIK 0001856296 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,007

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document
December 15, 2025 Filed Mar 4, 2026 21:43 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
SaleCommon Stock 25,000 $15.97 $399,250.00
Disclosure

SEC source: 0001855616-26-000007 · wk-form4_1772660606.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,964

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.26, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 21:30 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 1,338 $16.66 $22,291.08
Disclosure

SEC source: 0001855616-25-000007 · form4-12042025_041201.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,734

F1 · shares: Represents the number of shares withheld by the Issuer on December 3, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
November 27, 2025 Filed Dec 1, 2025 21:15 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 357 $16.50 $5,890.50
Disclosure

SEC source: 0001855616-25-000005 · form4-12012025_041201.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,072

F1 · shares: Represents the number of shares withheld by the Issuer on November 27, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
November 27, 2025 Filed Dec 1, 2025 21:15 UTC
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 1,126 $16.50 $18,579.00
Disclosure

SEC source: 0001533175-25-000004 · form4-12012025_041203.xml · nonDerivative · entry 1

Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,086

F1 · shares: Represents the number of shares withheld by the Issuer on November 27, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
November 20, 2025 Filed Nov 24, 2025 21:57 UTC
Morrell MarthaCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 3,051 $13.50 $41,188.50
Disclosure

SEC source: 0001855616-25-000003 · form4-11242025_091103.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,429

F1 · shares: Represents the number of shares withheld by the Issuer on November 20, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Read SEC document
September 19, 2025 Filed Sep 22, 2025 23:30 UTC
Geiger UriDirector
GrantCommon Stock 1,194 $9.94 $11,868.36
Disclosure

SEC source: 0001467361-25-000003 · form4-09222025_070908.xml · nonDerivative · entry 1

Geiger Uri · CIK 0001467361 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,230

F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.